Rapirosiran sodium is an N-acetylgalactosamine-conjugated small-interfering RNA that specifically targets hydroxysteroid 17-beta dehydrogenase 13 (HSD17B13) mRNA in the liver. It is associated with a reduction in the risk of chronic liver diseases due to loss-of-function variants in the HSD17B13 gene. This reagent is particularly valuable for research focused on non-alcoholic steatohepatitis, facilitating the exploration of therapeutic strategies targeting liver metabolism and inflammation.
Rapirosiran sodium is an N-acetylgalactosamine-conjugated small-interfering RNA that specifically targets hydroxysteroid 17-beta dehydrogenase 13 (HSD17B13) mRNA in the liver. It is associated with a reduction in the risk of chronic liver diseases due to loss-of-function variants in the HSD17B13 gene. This reagent is particularly valuable for research focused on non-alcoholic steatohepatitis, facilitating the exploration of therapeutic strategies targeting liver metabolism and inflammation.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
